Clinical results using biochemotherapy as a standard of care in advanced melanoma.
Times cited: 10
Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: A dose-response study.
Clinical Cancer Research.
Times cited: 88
Immunization of melanoma patients with antiidiotypic monoclonal antibody BEC2 (which mimics GD3 ganglioside): Pilot trials using no immunological adjuvant.
Times cited: 24